Women with luminal A subtype of breast cancer did not benefit from adjuvant chemother
 

Patients with other subtypes had benefit.Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or...

More...